Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Radin injection

Dexa Medica

Ingredients in every ml

Ranitidine HCl 25 mg

Each package contains

5 ampoules of 2 ml

Dosage form

injection

Dosage formInjection

Flavour

None

W.H.O. classification

A02B
A02B

A.T.C. Level 1

Anatomical Main group

A - Alimentary tract and metabolism
A02B

A.T.C. Level 2

Therapeutic subgroup

A02 - Drugs for Acid Related Disorders
A02B

A.T.C. Level 3

Pharmacological subgroup

A02B - Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)

Available in

Cambodia

Warnings

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

SAFE IF PRESCRIBEDThis item is safe for use while operating heavy machinery.

Pregnancy

CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

CAUTIONThis item may not be safe for use during lactation. Use with caution and after consultation with your doctor.

Indication

Active duodenal ulcer
Pathological gastric ulcer
Reflux esophagitis
Prevention of peptic ulcer relapse
Zollinger-Ellison syndrome

Dosage

18 YEARS OLD AND ABOVE
Intramuscular (IM) injection:
50 mg (no dilution necessary) every 6-8 hours.

Intravenous (IV) injection: intermittent.
- Intermittent bolus: 50 mg (2 ml) every 6-8 hours.
Dilute ranitidine injection 50 mg in 0.9% sodium chloride solution or other compatible IV solution to a concentration not greater than 2.5 mg/ml (total volume of 20 ml). Rate of injection should not exceed 4 ml/minutes (for 5 minutes).
- Intermittent infusion: 50 mg (2 ml) every 6-8 hours.
Dilute ranitidine injection 50 mg in 100 mL of 5% dextrose solution or other compatible IV solution to a concentration not greater than 0.5 mg/ml (total volume of 100 ml). Rate of infusion should not exceed 5-7 ml/minutes (for 15-20 minutes).
- Continuous IV infusion:
Dilute ranitidine 150 mg in 250 ml of 5% dextrose solution or other compatible IV solution and rate of infusion is 6.25 mg/hour for 24 hours.
For Zollinger-Ellison syndrome or other pathological hypersecretory conditions, ranitidine injection should be diluted to a concentration not greater than 2.5 mg/ml with 5% dextrose solution or other compatible IV solution. Initial infusion rate is 1 mg/kg body weight/hour and should be adjusted to patient's condition.

0 TO 18 YEARS OLD
Safety and efficacy in pediatrics has not been established